Global Flow Cytometry in Oncology and Immunology Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Page: 110
Published Date: 12 May 2023
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Flow Cytometry in Oncology and Immunology market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global increase in HIV diagnoses is a significant market factor for flow cytometry, and this is because the flow cytometry technique is specifically used for HIV diagnosis. In flow cytometry, light scattering is utilized to identify cells. These cells receive particular markers known as CDs depending on the type of scattering (clusters of differentiation). The main market players are concentrating on creating new products, which is anticipated to propel market growth over the forecast year.
Flow cytometry is a powerful technology that is widely used in both oncology and immunology research. It is a technique used to analyze the physical and chemical properties of cells in a heterogeneous population, by labeling and detecting specific molecules on the surface of cells. The resulting data can provide information about the number, size, and complexity of cells in a sample, as well as their phenotype and function.
In oncology, flow cytometry is often used to analyze cancer cells and to monitor the progression of the disease. For example, flow cytometry can be used to identify and quantify cancer stem cells, which are thought to be responsible for tumor initiation and recurrence. It can also be used to measure the expression of tumor-associated antigens, which are molecules expressed by cancer cells that can be targeted by immunotherapy.
Overall, flow cytometry is a versatile tool that has many applications in oncology and immunology research. It can provide valuable information about the biology of cells and their interactions with other cells and molecules, and can help researchers to develop new diagnostic and therapeutic approaches for cancer and other diseases
This report is a detailed and comprehensive analysis for global Flow Cytometry in Oncology and Immunology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Flow Cytometry in Oncology and Immunology market size and forecasts, in consumption value ($ Million), 2018-2029
Global Flow Cytometry in Oncology and Immunology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Flow Cytometry in Oncology and Immunology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Flow Cytometry in Oncology and Immunology market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Flow Cytometry in Oncology and Immunology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Flow Cytometry in Oncology and Immunology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent, ABYNTEK BIOPHARMA, Bio-Rad Laboratories, Cell Signaling Technology and Cytek Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Flow Cytometry in Oncology and Immunology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Products
Services
Market segment by Application
Immunology
Oncology
Solid Tumor
Market segment by players, this report covers
Agilent
ABYNTEK BIOPHARMA
Bio-Rad Laboratories
Cell Signaling Technology
Cytek Biosciences
Danaher Corporation,
DiaSorin S.p.A (Luminex Corporation),
Enzi Biochem Inc
Laboratory Corporation of America Holdings,
Merck KGaA
Miltenyi Biotec
NeoGenomics Laboratories
OPKO Health
Sony Group Corporation
Thermo Fisher Scientific Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Flow Cytometry in Oncology and Immunology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Flow Cytometry in Oncology and Immunology, with revenue, gross margin and global market share of Flow Cytometry in Oncology and Immunology from 2018 to 2023.
Chapter 3, the Flow Cytometry in Oncology and Immunology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Flow Cytometry in Oncology and Immunology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Flow Cytometry in Oncology and Immunology.
Chapter 13, to describe Flow Cytometry in Oncology and Immunology research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Flow Cytometry in Oncology and Immunology
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Flow Cytometry in Oncology and Immunology by Type
1.3.1 Overview: Global Flow Cytometry in Oncology and Immunology Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Type in 2022
1.3.3 Products
1.3.4 Services
1.4 Global Flow Cytometry in Oncology and Immunology Market by Application
1.4.1 Overview: Global Flow Cytometry in Oncology and Immunology Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Immunology
1.4.3 Oncology
1.4.4 Solid Tumor
1.5 Global Flow Cytometry in Oncology and Immunology Market Size & Forecast
1.6 Global Flow Cytometry in Oncology and Immunology Market Size and Forecast by Region
1.6.1 Global Flow Cytometry in Oncology and Immunology Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Flow Cytometry in Oncology and Immunology Market Size by Region, (2018-2029)
1.6.3 North America Flow Cytometry in Oncology and Immunology Market Size and Prospect (2018-2029)
1.6.4 Europe Flow Cytometry in Oncology and Immunology Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size and Prospect (2018-2029)
1.6.6 South America Flow Cytometry in Oncology and Immunology Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Flow Cytometry in Oncology and Immunology Market Size and Prospect (2018-2029)
2.1 Agilent
2.1.1 Agilent Details
2.1.2 Agilent Major Business
2.1.3 Agilent Flow Cytometry in Oncology and Immunology Product and Solutions
2.1.4 Agilent Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Agilent Recent Developments and Future Plans
2.2 ABYNTEK BIOPHARMA
2.2.1 ABYNTEK BIOPHARMA Details
2.2.2 ABYNTEK BIOPHARMA Major Business
2.2.3 ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Product and Solutions
2.2.4 ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ABYNTEK BIOPHARMA Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Product and Solutions
2.3.4 Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 Cell Signaling Technology
2.4.1 Cell Signaling Technology Details
2.4.2 Cell Signaling Technology Major Business
2.4.3 Cell Signaling Technology Flow Cytometry in Oncology and Immunology Product and Solutions
2.4.4 Cell Signaling Technology Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cell Signaling Technology Recent Developments and Future Plans
2.5 Cytek Biosciences
2.5.1 Cytek Biosciences Details
2.5.2 Cytek Biosciences Major Business
2.5.3 Cytek Biosciences Flow Cytometry in Oncology and Immunology Product and Solutions
2.5.4 Cytek Biosciences Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cytek Biosciences Recent Developments and Future Plans
2.6 Danaher Corporation,
2.6.1 Danaher Corporation, Details
2.6.2 Danaher Corporation, Major Business
2.6.3 Danaher Corporation, Flow Cytometry in Oncology and Immunology Product and Solutions
2.6.4 Danaher Corporation, Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Danaher Corporation, Recent Developments and Future Plans
2.7 DiaSorin S.p.A (Luminex Corporation),
2.7.1 DiaSorin S.p.A (Luminex Corporation), Details
2.7.2 DiaSorin S.p.A (Luminex Corporation), Major Business
2.7.3 DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Product and Solutions
2.7.4 DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 DiaSorin S.p.A (Luminex Corporation), Recent Developments and Future Plans
2.8 Enzi Biochem Inc
2.8.1 Enzi Biochem Inc Details
2.8.2 Enzi Biochem Inc Major Business
2.8.3 Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Product and Solutions
2.8.4 Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Enzi Biochem Inc Recent Developments and Future Plans
2.9 Laboratory Corporation of America Holdings,
2.9.1 Laboratory Corporation of America Holdings, Details
2.9.2 Laboratory Corporation of America Holdings, Major Business
2.9.3 Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Product and Solutions
2.9.4 Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Laboratory Corporation of America Holdings, Recent Developments and Future Plans
2.10 Merck KGaA
2.10.1 Merck KGaA Details
2.10.2 Merck KGaA Major Business
2.10.3 Merck KGaA Flow Cytometry in Oncology and Immunology Product and Solutions
2.10.4 Merck KGaA Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck KGaA Recent Developments and Future Plans
2.11 Miltenyi Biotec
2.11.1 Miltenyi Biotec Details
2.11.2 Miltenyi Biotec Major Business
2.11.3 Miltenyi Biotec Flow Cytometry in Oncology and Immunology Product and Solutions
2.11.4 Miltenyi Biotec Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Miltenyi Biotec Recent Developments and Future Plans
2.12 NeoGenomics Laboratories
2.12.1 NeoGenomics Laboratories Details
2.12.2 NeoGenomics Laboratories Major Business
2.12.3 NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Product and Solutions
2.12.4 NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 NeoGenomics Laboratories Recent Developments and Future Plans
2.13 OPKO Health
2.13.1 OPKO Health Details
2.13.2 OPKO Health Major Business
2.13.3 OPKO Health Flow Cytometry in Oncology and Immunology Product and Solutions
2.13.4 OPKO Health Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 OPKO Health Recent Developments and Future Plans
2.14 Sony Group Corporation
2.14.1 Sony Group Corporation Details
2.14.2 Sony Group Corporation Major Business
2.14.3 Sony Group Corporation Flow Cytometry in Oncology and Immunology Product and Solutions
2.14.4 Sony Group Corporation Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sony Group Corporation Recent Developments and Future Plans
2.15 Thermo Fisher Scientific Inc.
2.15.1 Thermo Fisher Scientific Inc. Details
2.15.2 Thermo Fisher Scientific Inc. Major Business
2.15.3 Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Product and Solutions
2.15.4 Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
3.1 Global Flow Cytometry in Oncology and Immunology Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Flow Cytometry in Oncology and Immunology by Company Revenue
3.2.2 Top 3 Flow Cytometry in Oncology and Immunology Players Market Share in 2022
3.2.3 Top 6 Flow Cytometry in Oncology and Immunology Players Market Share in 2022
3.3 Flow Cytometry in Oncology and Immunology Market: Overall Company Footprint Analysis
3.3.1 Flow Cytometry in Oncology and Immunology Market: Region Footprint
3.3.2 Flow Cytometry in Oncology and Immunology Market: Company Product Type Footprint
3.3.3 Flow Cytometry in Oncology and Immunology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Flow Cytometry in Oncology and Immunology Consumption Value and Market Share by Type (2018-2023)
4.2 Global Flow Cytometry in Oncology and Immunology Market Forecast by Type (2024-2029)
5.1 Global Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Application (2018-2023)
5.2 Global Flow Cytometry in Oncology and Immunology Market Forecast by Application (2024-2029)
6.1 North America Flow Cytometry in Oncology and Immunology Consumption Value by Type (2018-2029)
6.2 North America Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2029)
6.3 North America Flow Cytometry in Oncology and Immunology Market Size by Country
6.3.1 North America Flow Cytometry in Oncology and Immunology Consumption Value by Country (2018-2029)
6.3.2 United States Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
6.3.3 Canada Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
6.3.4 Mexico Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
7.1 Europe Flow Cytometry in Oncology and Immunology Consumption Value by Type (2018-2029)
7.2 Europe Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2029)
7.3 Europe Flow Cytometry in Oncology and Immunology Market Size by Country
7.3.1 Europe Flow Cytometry in Oncology and Immunology Consumption Value by Country (2018-2029)
7.3.2 Germany Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
7.3.3 France Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
7.3.5 Russia Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
7.3.6 Italy Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
8.1 Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region
8.3.1 Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value by Region (2018-2029)
8.3.2 China Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
8.3.3 Japan Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
8.3.4 South Korea Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
8.3.5 India Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
8.3.7 Australia Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
9.1 South America Flow Cytometry in Oncology and Immunology Consumption Value by Type (2018-2029)
9.2 South America Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2029)
9.3 South America Flow Cytometry in Oncology and Immunology Market Size by Country
9.3.1 South America Flow Cytometry in Oncology and Immunology Consumption Value by Country (2018-2029)
9.3.2 Brazil Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
9.3.3 Argentina Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
10.1 Middle East & Africa Flow Cytometry in Oncology and Immunology Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country
10.3.1 Middle East & Africa Flow Cytometry in Oncology and Immunology Consumption Value by Country (2018-2029)
10.3.2 Turkey Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
10.3.4 UAE Flow Cytometry in Oncology and Immunology Market Size and Forecast (2018-2029)
11.1 Flow Cytometry in Oncology and Immunology Market Drivers
11.2 Flow Cytometry in Oncology and Immunology Market Restraints
11.3 Flow Cytometry in Oncology and Immunology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12.1 Flow Cytometry in Oncology and Immunology Industry Chain
12.2 Flow Cytometry in Oncology and Immunology Upstream Analysis
12.3 Flow Cytometry in Oncology and Immunology Midstream Analysis
12.4 Flow Cytometry in Oncology and Immunology Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Flow Cytometry in Oncology and Immunology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Flow Cytometry in Oncology and Immunology Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Flow Cytometry in Oncology and Immunology Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Flow Cytometry in Oncology and Immunology Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Agilent Company Information, Head Office, and Major Competitors
Table 6. Agilent Major Business
Table 7. Agilent Flow Cytometry in Oncology and Immunology Product and Solutions
Table 8. Agilent Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Agilent Recent Developments and Future Plans
Table 10. ABYNTEK BIOPHARMA Company Information, Head Office, and Major Competitors
Table 11. ABYNTEK BIOPHARMA Major Business
Table 12. ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Product and Solutions
Table 13. ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. ABYNTEK BIOPHARMA Recent Developments and Future Plans
Table 15. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 16. Bio-Rad Laboratories Major Business
Table 17. Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Product and Solutions
Table 18. Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Bio-Rad Laboratories Recent Developments and Future Plans
Table 20. Cell Signaling Technology Company Information, Head Office, and Major Competitors
Table 21. Cell Signaling Technology Major Business
Table 22. Cell Signaling Technology Flow Cytometry in Oncology and Immunology Product and Solutions
Table 23. Cell Signaling Technology Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Cell Signaling Technology Recent Developments and Future Plans
Table 25. Cytek Biosciences Company Information, Head Office, and Major Competitors
Table 26. Cytek Biosciences Major Business
Table 27. Cytek Biosciences Flow Cytometry in Oncology and Immunology Product and Solutions
Table 28. Cytek Biosciences Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Cytek Biosciences Recent Developments and Future Plans
Table 30. Danaher Corporation, Company Information, Head Office, and Major Competitors
Table 31. Danaher Corporation, Major Business
Table 32. Danaher Corporation, Flow Cytometry in Oncology and Immunology Product and Solutions
Table 33. Danaher Corporation, Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Danaher Corporation, Recent Developments and Future Plans
Table 35. DiaSorin S.p.A (Luminex Corporation), Company Information, Head Office, and Major Competitors
Table 36. DiaSorin S.p.A (Luminex Corporation), Major Business
Table 37. DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Product and Solutions
Table 38. DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. DiaSorin S.p.A (Luminex Corporation), Recent Developments and Future Plans
Table 40. Enzi Biochem Inc Company Information, Head Office, and Major Competitors
Table 41. Enzi Biochem Inc Major Business
Table 42. Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Product and Solutions
Table 43. Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Enzi Biochem Inc Recent Developments and Future Plans
Table 45. Laboratory Corporation of America Holdings, Company Information, Head Office, and Major Competitors
Table 46. Laboratory Corporation of America Holdings, Major Business
Table 47. Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Product and Solutions
Table 48. Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Laboratory Corporation of America Holdings, Recent Developments and Future Plans
Table 50. Merck KGaA Company Information, Head Office, and Major Competitors
Table 51. Merck KGaA Major Business
Table 52. Merck KGaA Flow Cytometry in Oncology and Immunology Product and Solutions
Table 53. Merck KGaA Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Merck KGaA Recent Developments and Future Plans
Table 55. Miltenyi Biotec Company Information, Head Office, and Major Competitors
Table 56. Miltenyi Biotec Major Business
Table 57. Miltenyi Biotec Flow Cytometry in Oncology and Immunology Product and Solutions
Table 58. Miltenyi Biotec Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Miltenyi Biotec Recent Developments and Future Plans
Table 60. NeoGenomics Laboratories Company Information, Head Office, and Major Competitors
Table 61. NeoGenomics Laboratories Major Business
Table 62. NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Product and Solutions
Table 63. NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. NeoGenomics Laboratories Recent Developments and Future Plans
Table 65. OPKO Health Company Information, Head Office, and Major Competitors
Table 66. OPKO Health Major Business
Table 67. OPKO Health Flow Cytometry in Oncology and Immunology Product and Solutions
Table 68. OPKO Health Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. OPKO Health Recent Developments and Future Plans
Table 70. Sony Group Corporation Company Information, Head Office, and Major Competitors
Table 71. Sony Group Corporation Major Business
Table 72. Sony Group Corporation Flow Cytometry in Oncology and Immunology Product and Solutions
Table 73. Sony Group Corporation Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Sony Group Corporation Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Inc. Major Business
Table 77. Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Product and Solutions
Table 78. Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 80. Global Flow Cytometry in Oncology and Immunology Revenue (USD Million) by Players (2018-2023)
Table 81. Global Flow Cytometry in Oncology and Immunology Revenue Share by Players (2018-2023)
Table 82. Breakdown of Flow Cytometry in Oncology and Immunology by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Flow Cytometry in Oncology and Immunology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Flow Cytometry in Oncology and Immunology Players
Table 85. Flow Cytometry in Oncology and Immunology Market: Company Product Type Footprint
Table 86. Flow Cytometry in Oncology and Immunology Market: Company Product Application Footprint
Table 87. Flow Cytometry in Oncology and Immunology New Market Entrants and Barriers to Market Entry
Table 88. Flow Cytometry in Oncology and Immunology Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Flow Cytometry in Oncology and Immunology Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Flow Cytometry in Oncology and Immunology Consumption Value Share by Type (2018-2023)
Table 91. Global Flow Cytometry in Oncology and Immunology Consumption Value Forecast by Type (2024-2029)
Table 92. Global Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2023)
Table 93. Global Flow Cytometry in Oncology and Immunology Consumption Value Forecast by Application (2024-2029)
Table 94. North America Flow Cytometry in Oncology and Immunology Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Flow Cytometry in Oncology and Immunology Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Flow Cytometry in Oncology and Immunology Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Flow Cytometry in Oncology and Immunology Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Flow Cytometry in Oncology and Immunology Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Flow Cytometry in Oncology and Immunology Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Flow Cytometry in Oncology and Immunology Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Flow Cytometry in Oncology and Immunology Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Flow Cytometry in Oncology and Immunology Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Flow Cytometry in Oncology and Immunology Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Flow Cytometry in Oncology and Immunology Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Flow Cytometry in Oncology and Immunology Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Flow Cytometry in Oncology and Immunology Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Flow Cytometry in Oncology and Immunology Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Flow Cytometry in Oncology and Immunology Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Flow Cytometry in Oncology and Immunology Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Flow Cytometry in Oncology and Immunology Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Flow Cytometry in Oncology and Immunology Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Flow Cytometry in Oncology and Immunology Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Flow Cytometry in Oncology and Immunology Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Flow Cytometry in Oncology and Immunology Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Flow Cytometry in Oncology and Immunology Raw Material
Table 125. Key Suppliers of Flow Cytometry in Oncology and Immunology Raw Materials
List of Figures
Figure 1. Flow Cytometry in Oncology and Immunology Picture
Figure 2. Global Flow Cytometry in Oncology and Immunology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Type in 2022
Figure 4. Products
Figure 5. Services
Figure 6. Global Flow Cytometry in Oncology and Immunology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Application in 2022
Figure 8. Immunology Picture
Figure 9. Oncology Picture
Figure 10. Solid Tumor Picture
Figure 11. Global Flow Cytometry in Oncology and Immunology Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Flow Cytometry in Oncology and Immunology Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Flow Cytometry in Oncology and Immunology Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Region in 2022
Figure 16. North America Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Flow Cytometry in Oncology and Immunology Revenue Share by Players in 2022
Figure 22. Flow Cytometry in Oncology and Immunology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Flow Cytometry in Oncology and Immunology Market Share in 2022
Figure 24. Global Top 6 Players Flow Cytometry in Oncology and Immunology Market Share in 2022
Figure 25. Global Flow Cytometry in Oncology and Immunology Consumption Value Share by Type (2018-2023)
Figure 26. Global Flow Cytometry in Oncology and Immunology Market Share Forecast by Type (2024-2029)
Figure 27. Global Flow Cytometry in Oncology and Immunology Consumption Value Share by Application (2018-2023)
Figure 28. Global Flow Cytometry in Oncology and Immunology Market Share Forecast by Application (2024-2029)
Figure 29. North America Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 39. France Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Region (2018-2029)
Figure 46. China Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 49. India Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Flow Cytometry in Oncology and Immunology Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Flow Cytometry in Oncology and Immunology Consumption Value (2018-2029) & (USD Million)
Figure 63. Flow Cytometry in Oncology and Immunology Market Drivers
Figure 64. Flow Cytometry in Oncology and Immunology Market Restraints
Figure 65. Flow Cytometry in Oncology and Immunology Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Flow Cytometry in Oncology and Immunology in 2022
Figure 68. Manufacturing Process Analysis of Flow Cytometry in Oncology and Immunology
Figure 69. Flow Cytometry in Oncology and Immunology Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Agilent ABYNTEK BIOPHARMA Bio-Rad Laboratories Cell Signaling Technology Cytek Biosciences Danaher Corporation, DiaSorin S.p.A (Luminex Corporation), Enzi Biochem Inc Laboratory Corporation of America Holdings, Merck KGaA Miltenyi Biotec NeoGenomics Laboratories OPKO Health Sony Group Corporation Thermo Fisher Scientific Inc.
Related Reports
12 May 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
